A Random Selection of Patients From the SENTRY Study Who Have a Bioconverted Sentry IVC Filter in Situ With a Minimum Dwell Time of 24 Months From a Single Center Follow up
NCT04208139 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 11
Last updated 2022-04-06
Summary
IVUS Evaluation of the Bioabsorbable Sentry IVC Filter 3-5 Years Post Deployment Follow up
Conditions
- Recurrent Pulmonary Embolism (Disorder)
Interventions
- DIAGNOSTIC_TEST
-
IVUS
IVUS
Sponsors & Collaborators
-
Novate Medical Limited, a BTG Group Company
collaborator UNKNOWN -
NC Heart and Vascular Research, LLC
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-03-14
- Primary Completion
- 2020-09-21
- Completion
- 2020-10-01
- FDA Device
- Yes
Countries
- United States
Study Locations
More Related Trials
-
Safety and Efficacy Comparison Of Two TAVI Systems in a Prospective Randomized Evaluation II
NCT03192813 ·Status: COMPLETED
-
RESOLUTE ONYX Post-Approval Study
NCT03063749 ·Status: COMPLETED
-
Valiant Evo US Clinical Trial
NCT02652949 ·Status: COMPLETED ·Phase: NA
-
Valor II: The Valiant Thoracic Stent Graft System Clinical Study
NCT00413231 ·Status: COMPLETED ·Phase: NA
-
Symbiot III: A Prospective Randomized Trial Evaluating the Symbiot Covered Stent System in Saphenous Vein Grafts
NCT00283413 ·Status: COMPLETED ·Phase: NA
-
RevCore for In Stent Thrombosis
NCT06394739 ·Status: RECRUITING
-
PROTECT TAVI - Prospective Randomized Outcome Study in TAVI Patients Undergoing Periprocedural Embolic Cerebral Protection With the Sentinel™ Device
NCT02895737 ·Status: UNKNOWN ·Phase: NA
-
Evaluating the Clinical Effectiveness of a Patient-specific Silicone Stent
NCT05050591 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
RESILIENCE Trial: Evaluation of the Durability of Aortic Bioprostheses/Valves With RESILIA Tissue in Subjects Under 65
NCT03680040 ·Status: TERMINATED
-
EVOLVE Short DAPT Study
NCT02605447 ·Status: COMPLETED ·Phase: PHASE4
-
Valiant Evo International Clinical Trial
NCT02625324 ·Status: COMPLETED ·Phase: NA
-
A U.S Post Approval Study Evaluating the SYNERGY XLV (MEGATRON) Stent System
NCT04807439 ·Status: COMPLETED
-
REPRISE II: REpositionable Percutaneous Replacement of Stenotic Aortic Valve Through Implantation of Lotus™ Valve System
NCT01627691 ·Status: COMPLETED ·Phase: NA
-
Venous Stent for the Iliofemoral Vein Investigational Clinical Trial Using the DUO Venous Stent System
NCT04580160 ·Status: COMPLETED ·Phase: NA
-
Observational Study to Evaluate the BioMimics 3D Stent System: MIMICS-3D
NCT02900924 ·Status: COMPLETED
-
CHOICE: Carotid Stenting For High Surgical-Risk Patients
NCT00406055 ·Status: COMPLETED
-
Genomics of In-Stent Restenosis
NCT00341562 ·Status: COMPLETED
-
REpositionable Percutaneous Replacement of NatIve StEnotic Aortic Valve Through Implantation of LOTUS EDGE Valve System
NCT02854319 ·Status: TERMINATED ·Phase: NA
-
European Study Evaluating the EMBLOK Embolic Protection System During TAVR
NCT03130491 ·Status: COMPLETED ·Phase: NA
-
Carotid Filtration During Endovascular Aortic Valve Implantation
NCT01484249 ·Status: COMPLETED ·Phase: NA
-
Controlled Arterial Protection to Ultimately Remove Embolic Material
NCT06103591 ·Status: COMPLETED ·Phase: NA
-
The VIRTUE Post Marketing Surveillance Registry
NCT01213589 ·Status: COMPLETED
-
RESOLUTE ONYX Post-Approval Study (Bifurcation Cohort)
NCT03584464 ·Status: COMPLETED ·Phase: NA
-
SYNergy Stent® System Implantation With Mandatory Intra-VascularUltra-Sound Guidance and Dual Anti-Platelet Therapy
NCT03606642 ·Status: TERMINATED ·Phase: PHASE2
-
Evaluation of the Valiant Mona LSA Thoracic Stent Graft System in Descending TAA and Chronic Dissections
NCT02365467 ·Status: COMPLETED